The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in lieu of extensive method development and ...
WASHINGTON — Bottles of a popular anxiety medication are under recall nationwide for failing to meet dissolution requirements, the Food and Drug Administration said. In a recall notice on April 8, ...
Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...
A specific lot of the widely prescribed anti-anxiety drug Xanax has been recalled nationwide for not passing quality control tests concerning the time the pills take to dissolve, according to the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results